Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048805233> ?p ?o ?g. }
- W3048805233 endingPage "1558" @default.
- W3048805233 startingPage "1553" @default.
- W3048805233 abstract "In Brief Study Design. An epidemiological study using national administrative data from the MarketScan database. Objective. The aim of this study was to identify the impact of bone morphogenetic protein (BMP) on postoperative outcomes in patients undergoing adult cervical deformity (ACD) surgery. Summary of Background Data. BMP has been shown to stimulate bone growth and improve fusion rates in spine surgery. However, the impact of BMP on reoperation rates and postoperative complication rate is controversial. Methods. We queried the MarketScan database to identify patients who underwent ACD surgery from 2007 to 2015. Patients were stratified by BMP use in the index operation. Patients <18 years and those with any history of tumor or trauma were excluded. Baseline demographics and comorbidities, postoperative complication rates, and reoperation rates were analyzed. Results. A total of 13,549 patients underwent primary ACD surgery, of which 1155 (8.5%) had intraoperative BMP use. The overall 90-day complication rate was 27.6% in the non-BMP cohort and 31.1% in the BMP cohort (P < 0.05). Patients in the BMP cohort had longer average length of stay (4.0 days vs. 3.7 days, P < 0.05) but lower revision surgery rates at 90 days (14.5% vs. 28.3%, P < 0.05), 6 months (14.9% vs. 28.6%, P < 0.05), 1 year (15.7% vs. 29.2%, P < 0.05), and 2 years (16.5% vs. 29.9%, P < 0.05) postoperatively. BMP use was associated with higher payments throughout the 2-year follow-up period ($107,975 vs. $97,620, P < 0.05). When controlling for baseline group differences, BMP use independently increased the odds of postoperative complication (odds ratio [OR] 1.22, 95% confidence interval [CI] 1.1–1.4) and reduced the odds of reoperation throughout 2 years of follow-up (OR 0.49, 95% CI 0.4–0.6). Conclusion. Intraoperative BMP use has benefits for fusion integrity in ACD surgery but is associated with increased postoperative complication rate. Spine surgeons should weigh these benefits and drawbacks to identify optimal candidates for BMP use in ACD surgery. Level of Evidence: 3 A national claims database was queried to identify the impact of bone morphogenetic protein (BMP) on postoperative outcomes in patients undergoing adult cervical deformity (ACD) surgery.BMP use independently increased the odds for developing a postoperative complication and reduced the odds for reoperation throughout 2 years of follow-up." @default.
- W3048805233 created "2020-08-18" @default.
- W3048805233 creator A5021433932 @default.
- W3048805233 creator A5030913938 @default.
- W3048805233 creator A5049294948 @default.
- W3048805233 creator A5061003412 @default.
- W3048805233 creator A5064259976 @default.
- W3048805233 creator A5071236772 @default.
- W3048805233 creator A5073987272 @default.
- W3048805233 date "2020-07-31" @default.
- W3048805233 modified "2023-09-24" @default.
- W3048805233 title "Complications, Costs, and Quality Outcomes of Patients Undergoing Cervical Deformity Surgery With Intraoperative BMP Use" @default.
- W3048805233 cites W1959586137 @default.
- W3048805233 cites W1966639987 @default.
- W3048805233 cites W1968822620 @default.
- W3048805233 cites W1973535368 @default.
- W3048805233 cites W1974696817 @default.
- W3048805233 cites W1976043904 @default.
- W3048805233 cites W1979682230 @default.
- W3048805233 cites W1997328492 @default.
- W3048805233 cites W2007539757 @default.
- W3048805233 cites W2010719955 @default.
- W3048805233 cites W2023896320 @default.
- W3048805233 cites W2036358360 @default.
- W3048805233 cites W2039839585 @default.
- W3048805233 cites W2050622412 @default.
- W3048805233 cites W2055909856 @default.
- W3048805233 cites W2057067590 @default.
- W3048805233 cites W2059053909 @default.
- W3048805233 cites W2059284624 @default.
- W3048805233 cites W2060910232 @default.
- W3048805233 cites W2065772891 @default.
- W3048805233 cites W2074645659 @default.
- W3048805233 cites W2101430383 @default.
- W3048805233 cites W2114948268 @default.
- W3048805233 cites W2125728570 @default.
- W3048805233 cites W2139639812 @default.
- W3048805233 cites W2154128099 @default.
- W3048805233 cites W2155173703 @default.
- W3048805233 cites W2164833748 @default.
- W3048805233 cites W2314272269 @default.
- W3048805233 cites W2326850503 @default.
- W3048805233 cites W2329311838 @default.
- W3048805233 cites W2340112049 @default.
- W3048805233 cites W2592995616 @default.
- W3048805233 cites W2595299142 @default.
- W3048805233 cites W2885388307 @default.
- W3048805233 cites W2968238808 @default.
- W3048805233 cites W2969155909 @default.
- W3048805233 cites W2969210046 @default.
- W3048805233 doi "https://doi.org/10.1097/brs.0000000000003629" @default.
- W3048805233 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32756275" @default.
- W3048805233 hasPublicationYear "2020" @default.
- W3048805233 type Work @default.
- W3048805233 sameAs 3048805233 @default.
- W3048805233 citedByCount "4" @default.
- W3048805233 countsByYear W30488052332021 @default.
- W3048805233 countsByYear W30488052332022 @default.
- W3048805233 crossrefType "journal-article" @default.
- W3048805233 hasAuthorship W3048805233A5021433932 @default.
- W3048805233 hasAuthorship W3048805233A5030913938 @default.
- W3048805233 hasAuthorship W3048805233A5049294948 @default.
- W3048805233 hasAuthorship W3048805233A5061003412 @default.
- W3048805233 hasAuthorship W3048805233A5064259976 @default.
- W3048805233 hasAuthorship W3048805233A5071236772 @default.
- W3048805233 hasAuthorship W3048805233A5073987272 @default.
- W3048805233 hasBestOaLocation W30488052332 @default.
- W3048805233 hasConcept C126322002 @default.
- W3048805233 hasConcept C141071460 @default.
- W3048805233 hasConcept C167135981 @default.
- W3048805233 hasConcept C71924100 @default.
- W3048805233 hasConcept C72563966 @default.
- W3048805233 hasConcept C81182388 @default.
- W3048805233 hasConceptScore W3048805233C126322002 @default.
- W3048805233 hasConceptScore W3048805233C141071460 @default.
- W3048805233 hasConceptScore W3048805233C167135981 @default.
- W3048805233 hasConceptScore W3048805233C71924100 @default.
- W3048805233 hasConceptScore W3048805233C72563966 @default.
- W3048805233 hasConceptScore W3048805233C81182388 @default.
- W3048805233 hasIssue "22" @default.
- W3048805233 hasLocation W30488052331 @default.
- W3048805233 hasLocation W30488052332 @default.
- W3048805233 hasOpenAccess W3048805233 @default.
- W3048805233 hasPrimaryLocation W30488052331 @default.
- W3048805233 hasRelatedWork W2003938723 @default.
- W3048805233 hasRelatedWork W2047967234 @default.
- W3048805233 hasRelatedWork W2118496982 @default.
- W3048805233 hasRelatedWork W2364998975 @default.
- W3048805233 hasRelatedWork W2369162477 @default.
- W3048805233 hasRelatedWork W2369768841 @default.
- W3048805233 hasRelatedWork W2439875401 @default.
- W3048805233 hasRelatedWork W2603773853 @default.
- W3048805233 hasRelatedWork W4238867864 @default.
- W3048805233 hasRelatedWork W2525756941 @default.
- W3048805233 hasVolume "45" @default.
- W3048805233 isParatext "false" @default.
- W3048805233 isRetracted "false" @default.
- W3048805233 magId "3048805233" @default.
!["In Brief Study Design. An epidemiological study using national administrative data from the MarketScan database. Objective. The aim of this study was to identify the impact of bone morphogenetic protein (BMP) on postoperative outcomes in patients undergoing adult cervical deformity (ACD) surgery. Summary of Background Data. BMP has been shown to stimulate bone growth and improve fusion rates in spine surgery. However, the impact of BMP on reoperation rates and postoperative complication rate is controversial. Methods. We queried the MarketScan database to identify patients who underwent ACD surgery from 2007 to 2015. Patients were stratified by BMP use in the index operation. Patients <18 years and those with any history of tumor or trauma were excluded. Baseline demographics and comorbidities, postoperative complication rates, and reoperation rates were analyzed. Results. A total of 13,549 patients underwent primary ACD surgery, of which 1155 (8.5%) had intraoperative BMP use. The overall 90-day complication rate was 27.6% in the non-BMP cohort and 31.1% in the BMP cohort (P < 0.05). Patients in the BMP cohort had longer average length of stay (4.0 days vs. 3.7 days, P < 0.05) but lower revision surgery rates at 90 days (14.5% vs. 28.3%, P < 0.05), 6 months (14.9% vs. 28.6%, P < 0.05), 1 year (15.7% vs. 29.2%, P < 0.05), and 2 years (16.5% vs. 29.9%, P < 0.05) postoperatively. BMP use was associated with higher payments throughout the 2-year follow-up period ($107,975 vs. $97,620, P < 0.05). When controlling for baseline group differences, BMP use independently increased the odds of postoperative complication (odds ratio [OR] 1.22, 95% confidence interval [CI] 1.1–1.4) and reduced the odds of reoperation throughout 2 years of follow-up (OR 0.49, 95% CI 0.4–0.6). Conclusion. Intraoperative BMP use has benefits for fusion integrity in ACD surgery but is associated with increased postoperative complication rate. Spine surgeons should weigh these benefits and drawbacks to identify optimal candidates for BMP use in ACD surgery. Level of Evidence: 3 A national claims database was queried to identify the impact of bone morphogenetic protein (BMP) on postoperative outcomes in patients undergoing adult cervical deformity (ACD) surgery.BMP use independently increased the odds for developing a postoperative complication and reduced the odds for reoperation throughout 2 years of follow-up."](?object=%22In%20Brief%20Study%20Design.%20An%20epidemiological%20study%20using%20national%20administrative%20data%20from%20the%20MarketScan%20database.%20Objective.%20The%20aim%20of%20this%20study%20was%20to%20identify%20the%20impact%20of%20bone%20morphogenetic%20protein%20(BMP)%20on%20postoperative%20outcomes%20in%20patients%20undergoing%20adult%20cervical%20deformity%20(ACD)%20surgery.%20Summary%20of%20Background%20Data.%20BMP%20has%20been%20shown%20to%20stimulate%20bone%20growth%20and%20improve%20fusion%20rates%20in%20spine%20surgery.%20However%2C%20the%20impact%20of%20BMP%20on%20reoperation%20rates%20and%20postoperative%20complication%20rate%20is%20controversial.%20Methods.%20We%20queried%20the%20MarketScan%20database%20to%20identify%20patients%20who%20underwent%20ACD%20surgery%20from%202007%20to%202015.%20Patients%20were%20stratified%20by%20BMP%20use%20in%20the%20index%20operation.%20Patients%20%3C18%20years%20and%20those%20with%20any%20history%20of%20tumor%20or%20trauma%20were%20excluded.%20Baseline%20demographics%20and%20comorbidities%2C%20postoperative%20complication%20rates%2C%20and%20reoperation%20rates%20were%20analyzed.%20Results.%20A%20total%20of%2013%2C549%20patients%20underwent%20primary%20ACD%20surgery%2C%20of%20which%201155%20(8.5%25)%20had%20intraoperative%20BMP%20use.%20The%20overall%2090-day%20complication%20rate%20was%2027.6%25%20in%20the%20non-BMP%20cohort%20and%2031.1%25%20in%20the%20BMP%20cohort%20(P%20%3C%200.05).%20Patients%20in%20the%20BMP%20cohort%20had%20longer%20average%20length%20of%20stay%20(4.0%20days%20vs.%203.7%20days%2C%20P%20%3C%200.05)%20but%20lower%20revision%20surgery%20rates%20at%2090%20days%20(14.5%25%20vs.%2028.3%25%2C%20P%20%3C%200.05)%2C%206%20months%20(14.9%25%20vs.%2028.6%25%2C%20P%20%3C%200.05)%2C%201%20year%20(15.7%25%20vs.%2029.2%25%2C%20P%20%3C%200.05)%2C%20and%202%20years%20(16.5%25%20vs.%2029.9%25%2C%20P%20%3C%200.05)%20postoperatively.%20BMP%20use%20was%20associated%20with%20higher%20payments%20throughout%20the%202-year%20follow-up%20period%20(%24107%2C975%20vs.%20%2497%2C620%2C%20P%20%3C%200.05).%20When%20controlling%20for%20baseline%20group%20differences%2C%20BMP%20use%20independently%20increased%20the%20odds%20of%20postoperative%20complication%20(odds%20ratio%20%5BOR%5D%201.22%2C%2095%25%20confidence%20interval%20%5BCI%5D%201.1%E2%80%931.4)%20and%20reduced%20the%20odds%20of%20reoperation%20throughout%202%20years%20of%20follow-up%20(OR%200.49%2C%2095%25%20CI%200.4%E2%80%930.6).%20Conclusion.%20Intraoperative%20BMP%20use%20has%20benefits%20for%20fusion%20integrity%20in%20ACD%20surgery%20but%20is%20associated%20with%20increased%20postoperative%20complication%20rate.%20Spine%20surgeons%20should%20weigh%20these%20benefits%20and%20drawbacks%20to%20identify%20optimal%20candidates%20for%20BMP%20use%20in%20ACD%20surgery.%20Level%20of%20Evidence%3A%203%20A%20national%20claims%20database%20was%20queried%20to%20identify%20the%20impact%20of%20bone%20morphogenetic%20protein%20(BMP)%20on%20postoperative%20outcomes%20in%20patients%20undergoing%20adult%20cervical%20deformity%20(ACD)%20surgery.BMP%20use%20independently%20increased%20the%20odds%20for%20developing%20a%20postoperative%20complication%20and%20reduced%20the%20odds%20for%20reoperation%20throughout%202%20years%20of%20follow-up.%22){kind=link}